In this piece, we will take a look at the five best stocks to buy for a quick return. For more stocks, head on over to 10 Best Stocks to Buy for a Quick Return.
5. Grove Collaborative Holdings, Inc. (NYSE:GROV)
One Month Volatility: 14.32%
Grove Collaborative Holdings, Inc. (NYSE:GROV) provides cleaning, home, pantry, beauty, and other products. The firm is based in San Francisco, California.
Grove Collaborative Holdings, Inc. (NYSE:GROV) announced in March 2023 that it has partnered up with Drew Barrymore to launch two new product lineups. 13 of the 943 hedge funds polled by Insider Monkey had invested in the firm during Q4 2022.
Follow Grove Collaborative Holdings Inc.
Follow Grove Collaborative Holdings Inc.
4. Southland Holdings, Inc. (NYSE:SLND)
One Month Volatility: 14.51%
Southland Holdings, Inc. (NYSE:SLND) is one of the oldest companies on our list as it was set up in 1900. The firm builds civil engineering projects such as buildings and tunnels. It is headquartered in Grapevine, Texas.
Southland Holdings, Inc. (NYSE:SLND)’s shares faced extreme volatility in February 2023 after it announced that it will transfer its listing from the NASDAQ to the NYSE. The announcement came a day after its shares had started to trade on the NASDAQ.
Southland Holdings, Inc. (NYSE:SLND)’s largest investor in our database is Phill Gross and Robert Atchinson’s Adage Capital Management. It owns 1.8 million shares that are worth $18.3 million.
Follow Southland Holdings Inc.
Follow Southland Holdings Inc.
3. GreenLight Biosciences Holdings (NASDAQ:GRNA)
One Month Volatility: 14.55%
GreenLight Biosciences Holdings (NASDAQ:GRNA) is an American healthcare company headquartered in Medford, Massachusetts. The firm develops treatments and vaccines for both humans and crops.
GreenLight Biosciences Holdings (NASDAQ:GRNA) scored a win in February 2023 after Rwanda approved its COVID-19 vaccine to start a trial as a booster dose. By the end of last year’s December quarter, eight of the 943 hedge funds polled by Insider Monkey had invested in the company.
Out of these, Ben Levine, Andrew Manuel, and Stefan Renold’s LMR Partners is GreenLight Biosciences Holdings (NASDAQ:GRNA)’s largest shareholder. It owns 2.9 million shares that are worth $3.4 million.
Follow Greenlight Biosciences Holdings Pbc
Follow Greenlight Biosciences Holdings Pbc
2. Kala Pharmaceuticals, Inc. (NASDAQ:KALA)
One Month Volatility: 16.28%
Kala Pharmaceuticals, Inc. (NASDAQ:KALA) is a health company that focuses on developing treatments for eye diseases such as defects and problems following surgery. It is based in Watertown, Massachusetts.
Kala Pharmaceuticals, Inc. (NASDAQ:KALA)’s investors were in for some good news in March 2023, when H.C. Wainwright increased the firm’s share price target to $20 from $12 and kept a buy rating on the shares following strong FY2022 results. Four of the 943 hedge funds surveyed by Insider Monkey had held a stake in the firm during Q4 2022.
Kala Pharmaceuticals, Inc. (NASDAQ:KALA)’s largest investor in our database is Julian Baker and Felix Baker’s Baker Bros. Advisors which owns 76,813 shares that are worth $2.9 million.
Follow Kala Bio Inc. (NASDAQ:KALA)
Follow Kala Bio Inc. (NASDAQ:KALA)
1. Windtree Therapeutics, Inc. (NASDAQ:WINT)
One Month Volatility: 18.44%
Windtree Therapeutics, Inc. (NASDAQ:WINT) is a healthcare company headquartered in Warrington, Pennsylvania. It develops treatments for heart diseases such as heart failure and hypertension, as well as lung injuries.
Windtree Therapeutics, Inc. (NASDAQ:WINT) announced in March 2023 that its cardiogenic shock drug has the potential to decrease hospital stay durations. Four of the 943 hedge funds part of Insider Monkey’s database had held a stake in the firm during last year’s December quarter.
Follow Windtree Therapeutics Inc (NASDAQ:WINT)
Follow Windtree Therapeutics Inc (NASDAQ:WINT)
Disclosure: None. You can also take a look at 10 High-Growth Lithium Stocks to Buy and 12 Dividend Giants with Lowest Short Interest.
Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below